About
DxLab Inc. (DxLab; www.dxlab.bio) is a biotech startup founded by MIT and Harvard graduates in September 2020, developing and commercializing a next-generation point-of-care (POC) diagnostic solution for rapid, on-site detection of dangerous pathogens. Combining proprietary platform technology with novel target detection and signal processing methods, we are advancing a pipeline of rapid and accessible POC tests to keep everyone safe from ever increasing pathogens that threaten our health.